Mainland China’s regulatory evolution brings greater access to novel drugs
Clarivate
MAY 11, 2023
The following year, the Mainland Chinese government empaneled a working committee comprised of experts from the State Council (SC) and the National Health Commission (NHC) to identify drugs already approved in western market sand urgently needed in Mainland China.
52 
Let's personalize your content